Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
In cancer research settings, AI has shown strong capabilities for predicting risk, recurrence and survivability over the past 10-plus years. Yet real-world cancer mortality remains largely unchanged to the present day. Why is that?
AI should not be used to predict the course of clinical depression if all it has to work with are new patients’ medical records of past diagnoses, medications, encounters and patient-reported outcomes.
AI and machine learning are adept at selecting good candidates for total joint arthroplasty and predicting which patients will and won’t experience post-op complications.
Nearly 3 million Americans gained healthcare coverage during the special enrollment period (SEP) created by President Joe Biden, the White House announced.
Expanding Medicaid is associated with better health outcomes at federally qualified health centers (FQHCs), according to a recent study published in JAMA.
